vimarsana.com

Latest Breaking News On - Founder branislav vajdic - Page 2 : vimarsana.com

HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time

HeartBeam, Inc. , a cardiac technology company that has developed the first and only 3D-vector electrocardiogram platform intended for patient use at home, will hold a conference call on Thursday.

United-states
Richard-brounstein
Robert-eno
Branislav-vajdic
Heartbeam-aimigo
Nasdaq
Drug-administration
Heartbeam-inc
Thursday-august
Founder-branislav-vajdic
President-robert-eno
Risk-factors

HeartBeam Reports First Quarter 2023 Financial Results

Closed $26.5 Million with a Public Offering and Registered Direct Offering to Enable Company to Execute on Upcoming Clinical, Regulatory and Commercial Milestones and Extend Cash Runway into Late. | May 11, 2023

United-states
Branislav-vajdic
Richard-brounstein
Heartbeam-aimigo
Robert-eno
Heartbeam-inc
Drug-administration
Nasdaq
Registered-direct-offering
Atrial-fibrillation-detection-system
Chief-executive-officer
Atrial-fibrillation-detection

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

California
United-states
San-francisco
Branislav-vajdic
Bmw
Heartbeam-inc
Drug-administration
Founder-branislav-vajdic
Phones-only

HeartBeam, Inc.: HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

Patented Technology Provides Protection for HeartBeam AIMIGo Credit Card-sized Device in European Market HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first

Germany
United-states
Netherlands
United-kingdom
France
Chris-tyson
Heartbeam-aimigo
Branislav-vajdic
Heartbeam-inc
European-patent-office
European-society-of-cardiology
Drug-administration

HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

05.01.2023 - HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent that enables generation of a synthesized 12-lead . Seite 1

Germany
Netherlands
United-kingdom
France
Heartbeam-aimigo
Branislav-vajdic
Heartbeam-inc
European-patent-office
European-society-of-cardiology
Nasdaq
European-patent
European-society

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.